Genopathy
Gene-Disorder Association · Article
Gene
APOA2
Apolipoprotein A2
Disorder
Hypercholesterolemia, Familial, 2
First reported 1974
Key publication · disorder Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.The Journal of biological chemistry · 1974
Manually curated
Association Review

In brief

The association between APOA2 (Apolipoprotein A2) and Hypercholesterolemia, Familial, 2 is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 9
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
APOA2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Hypercholesterolemia, Familial, 2

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

5 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Mechanism overlap

Shared mechanisms

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
07
Provenance

References & sources

4 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access